Objectives:

1. To defi ne and describe the clinical syndrome of new-onset refractory status epileptics (NORSE);
2. To discuss the diagnostic and therapeutic approach to NORSE; and
3. To explore the potential role for early immunotherapy in the management of NORSE

 

Session date: 
Thursday, December 21, 2017 - 3:00pm to 4:00pm
Location: 
UCMC
Chicago, IL 60637
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.